Published in Lab Business Week, January 8th, 2006
"Since nucleic acid techniques remain expensive and largely unavailable in many laboratories in the developing world, the present study assesses the clinical usefulness of the HCV core antigen enzyme immunoassay for the diagnosis of HCV infection in dialysis patients," wrote N. Bouzgarrou and colleagues, Laboratory of Molecular Immuno-Oncology.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week